Cat.#: ASSD-139
| Description | Adenosine A1AR Affinity-Based Probe (AfBP) incubate with live cells or membrane fractions can selectively label the desired receptor in the presence of other proteins. AfBP acts as a partial agonist which is highly specific to the A1AR and binds covalently. Apparent pKi values at A1AR are 7.8 and 9.5 (following a 4h preincubation), where a Ki shift indicates a covalent mode of action. |
| Size | 50 μg |
| Applications | For use in confocal microscopy, SDS-PAGE and chemical proteomics profiling applications. |
| Chemical Name | 4-((3-((6-Amino-4-(benzo[d][1,3]dioxol-5-yl)-3,5-dicyanopyridin-2-yl)thio)propyl)(prop-2-yn-1-yl)carbamoyl)benzenesulfonyl fluoride |
| Molecule Weight | 577.6 |
| Molecular formula | C27H20FN5O5S2 |
| PubChem identifier | 167312224 |
| Purity | >95% |
| Solubility | Soluble in DMSO |
| Storage | Store at -20° C |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ASSD-121 | Fluorescent adenosine A3 antagonist [XAC] (AC121) | 500 μg | inquiry |
| ASSD-199 | 4,7-Dioxaoctylenediamine N-[(Cyanine 3) Monofunctional Hexanoic Acid]-N′-[2-fluoro-4′-phosphophenylacetic Acid] Diamide (AC199) | 500 μg | inquiry |
| ASSD-136 | LUF7445/A2A antagonist (AC136) | 50 μg | inquiry |
| ASSD-228 | ImmunoHistoMount (AC228) | 30 ml | inquiry |
| ASSD-104 | Hoechst 33258 (AC104) | 25 mg, 100 mg | inquiry |
| ASSD-226 | Antifade Fluorescence Mounting Medium (hard set) (AC226) | 10 mL | inquiry |
| ASSD-202 | 5(6)-Carboxytetramethylrhodamine (AC202) | 100 mg, 250 mg | inquiry |
| ASSD-193 | N-(Aminoethyl)-5-naphthylamine-1-sulfonic Acid (AC193) | 1 g | inquiry |
| ASSD-212 | 5(6)-Carboxy-2′,7′-dichlorofluorescein diacetate N-succinimidyl ester (AC212) | 25 mg | inquiry |
| ASSD-149 | D-Luciferin sodium salt (AC149) | 10 mg, 50 mg, 100 mg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.